Prenetics Global Limited Class A Ordinary Share (PRE) Stock Price
PREStock
$18.52+16.77%52W
Market Cap$361.40M
P/E—
PEG Ratio—
Div yield—
Beta0.34
PRE Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-7.07%
Price vs S&P 500 (4W)-22.59%
VGM Score48.64
PRE Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.48 | -$0.52 | -8.33%(-$0.04) | |
| Q1 2026 | -$0.78 | -$1.36 | -75.48%(-$0.59) | |
| Q4 2025 | -$0.52 | -$0.19 | +63.18%(+$0.33) | |
| Q3 2025 | -$0.55 | -$0.53 | +3.64%(+$0.02) | |
| Q2 2025 | -$0.71 | -$0.94 | -32.39%(-$0.23) |
PRE Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.00
4.00
4.00
4.00
Industry Peers — Lab Analytical Instruments(25)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
PREPrenetics Global Limited Class A Ordinary Share | C | D | C | 2.7x | 58.6% | 63.7% | -41.8% | $18.52 |
| AAgilent Technologies Inc. | D | C | A | 6.6x | 5.4% | 53.9% | 22.2% | $172.97 |
| WATWaters Corp | F | C | A | 9.4x | 6.0% | 50.9% | 7.1% | $436.95 |
| ILMNIllumina Inc | D | D | A | 8.8x | 6.0% | 66.4% | 19.5% | $262.54 |
| MTDMettler-Toledo International | D | C | A | 7.9x | 5.5% | 60.3% | 26.6% | $1622.29 |
| RVTYRevvity, Inc. | D | D | A | 5.8x | -5.5% | 55.0% | 12.3% | $152.64 |
| AVTRAvantor, Inc. | C | F | A | 1.7x | 0.5% | 31.8% | -4.7% | $16.42 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $364.15 |
| BIOBio-Rad Laboratories, Inc.Class A | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $353.70 |
| TXG10x Genomics, Inc. Class A Common Stock | F | D | A | 14.8x | 16.6% | 69.6% | -14.3% | $69.86 |
| BRKRBruker Corporation | D | D | B | 2.4x | 11.6% | 47.7% | -1.5% | $54.80 |
About Prenetics Global Limited Class A Ordinary Share
Prenetics Global Ltd is a diversified health sciences company operating three consumer healthcare brands: IM8 (a fast-growing supplement brand), Europa (sports distribution in the USA), and CircleDNA (direct-to-consumer DNA testing). The company has established a Bitcoin treasury with an initial approximately $20 million investment and a board-approved comprehensive digital asset strategy, positioning itself at the intersection of healthcare innovation and digital assets.